We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares

120 hedge funds and large institutions have $657M invested in NovaBridge Biosciences American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 58 increasing their positions, 22 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 22

0.14% more ownership

Funds ownership: 21.79%21.93% (+0.14%)

9% less funds holding

Funds holding: 132120 (-12)

36% less call options, than puts

Call options by funds: $3.45M | Put options by funds: $5.36M

39% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 28

40% less funds holding in top 10

Funds holding in top 10: 106 (-4)

64% less capital invested

Capital invested by funds: $1.83B → $657M (-$1.17B)

Holders
120
Holders Change
-12
Holders Change %
-9.09%
% of All Funds
1.89%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.09%
New
17
Increased
58
Reduced
22
Closed
28
Calls
$3.45M
Puts
$5.36M
Net Calls
-$1.91M
Net Calls Change
-$2.33M
Name Holding Trade Value Shares
Change
Change in
Stake
EMG
76
ETF Managers Group
New Jersey
$459K +$16.6K +648 +3%
PAM
77
Panagora Asset Management
Massachusetts
$429K +$328K +12,812 +94%
HS
78
HighVista Strategies
Massachusetts
$413K +$651K +25,402 New
Mitsubishi UFJ Trust & Banking
79
Mitsubishi UFJ Trust & Banking
Japan
$380K
DekaBank Deutsche Girozentrale
80
DekaBank Deutsche Girozentrale
Germany
$323K -$496K -19,371 -86%
EFMH
81
E Fund Management (HK)
Hong Kong
$318K +$338K +13,171 +139%
KFA
82
Krane Funds Advisors
New York
$308K +$47.1K +1,837 +11%
Mitsubishi UFJ Asset Management
83
Mitsubishi UFJ Asset Management
Japan
$294K +$202K +7,900 +77%
GCP
84
GSA Capital Partners
United Kingdom
$288K +$454K +17,709 New
Aviva
85
Aviva
United Kingdom
$283K +$69.2K +2,700 +18%
Susquehanna International Group
86
Susquehanna International Group
Pennsylvania
$278K +$317K +12,354 +258%
BCIM
87
British Columbia Investment Management
British Columbia, Canada
$258K
Jane Street
88
Jane Street
New York
$236K +$373K +14,571 New
Public Sector Pension Investment Board (PSP Investments)
89
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$223K
First Trust Advisors
90
First Trust Advisors
Illinois
$199K -$14.6K -570 -4%
SEI Investments
91
SEI Investments
Pennsylvania
$198K +$183K +7,151 +141%
Asset Management One
92
Asset Management One
Japan
$179K
TI
93
Trexquant Investment
Connecticut
$168K +$266K +10,367 New
Zurich Cantonal Bank
94
Zurich Cantonal Bank
Switzerland
$149K -$36.7K -1,432 -14%
SAM
95
Storebrand Asset Management
Norway
$139K
TRCT
96
Tower Research Capital (TRC)
New York
$84K +$108K +4,227 +440%
IMCOOI
97
Investment Management Corp of Ontario (IMCO)
Canada
$65K
Russell Investments Group
98
Russell Investments Group
United Kingdom
$65K
Acadian Asset Management
99
Acadian Asset Management
Massachusetts
$65K +$103K +4,023 New
VEA
100
Virtus ETF Advisers
New York
$51K -$4.84K -189 -6%

NBP Hedge Fund Activity: Q1 2022 in Review

120 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2022, worth a combined $657M — down 64% from $1.83B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of NBP and 17 opened new positions — a net loss of 11 holders — while 22 trimmed existing stakes and 58 added.

The largest buyer was Artisan Partners, adding an estimated $26M. The largest seller was T. Rowe Price Associates, cutting an estimated $50.1M.

  • 120 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2022, down from 132 in Q4 2021.
  • Funds reported $657M of NovaBridge Biosciences American Depositary Shares stock for Q1 2022, down 64% quarter-over-quarter.
  • 17 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2022 and 28 closed out, a net change of -11 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2022 was Artisan Partners, an estimated $26M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2022 was T. Rowe Price Associates, an estimated $50.1M sold.

Based on aggregated 13F filings for Q1 2022.